Immunome, Inc.
- Biotech or pharma, therapeutic R&D
Immunome (NASDAQ:IMNM) is a biotechnology company with a unique and powerful discovery engine that deeply interrogates human memory B-cell response to simultaneously identify novel targets as well as patient-derived antibodies that bind to those targets.